Search results
H.C. Wainwright cuts Biogen shares target on Leqembi uptake issues By Investing.com
Investing.com· 7 days agoOn Thursday, H.C. Wainwright adjusted its outlook on Biogen (NASDAQ:BIIB), reducing the price target...
Decoding Biogen Inc (BIIB): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 6 days agoBiogen Inc's robust product portfolio and pipeline offer a competitive edge in the neurology and immunology sectors. Despite a slight revenue dip, Biogen
Brokerages Set Biogen Inc. (NASDAQ:BIIB) Price Target at $295.58
ETF DAILY NEWS· 6 days agoShares of Biogen Inc. (NASDAQ:BIIB – Get Free Report) have earned a consensus rating of “Moderate Buy” from the twenty-seven research firms that are covering the company, ...
Biogen’s TOFIDENCE biosimilar moves closer to EU approval By Investing.com
Investing.com· 7 days agoBiogen Inc. (NASDAQ:BIIB) announced today that the European Medicines Agency's Committee for...
Shareholders 30% loss in Biogen (NASDAQ:BIIB) partly attributable to the company's decline in...
Simply Wall St. via Yahoo Finance· 7 days agoInvestors can approximate the average market return by buying an index fund. Active investors aim to...
Biogen (BIIB)'s Market Evaluation: A Fair Valuation Analysis
Guru Focus· 3 days agoBiogen Inc (BIIB, Financial) has recently experienced a daily gain of 4.43%, but this contrasts with a three-month loss of -12.67%. This article aims to delve into the valuation ...
Biogen Inc. (NASDAQ:BIIB) Just Released Its First-Quarter Earnings: Here's What Analysts Think
Simply Wall St. via Yahoo Finance· 5 days agoIt's been a good week for Biogen Inc. (NASDAQ:BIIB) shareholders, because the company has just...
Biogen Inc. (NASDAQ:BIIB) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 7 days agoBiogen Inc. (NASDAQ:BIIB) Q1 2024 Earnings Call Transcript April 24, 2024 Biogen Inc. misses on...
Biogen First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Simply Wall St. via Yahoo Finance· 4 days agoBiogen (NASDAQ:BIIB) First Quarter 2024 Results Key Financial Results Revenue: US$2.29b (down 7.0%...
William Blair Weighs in on Biogen Inc.’s Q3 2024 Earnings (NASDAQ:BIIB)
ETF DAILY NEWS· 3 days agoBiogen Inc. (NASDAQ:BIIB – Free Report) – Investment analysts at William Blair upped their Q3 2024 earnings per share (EPS) estimates for shares of Biogen